{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:01:16Z","timestamp":1783983676745,"version":"3.55.0"},"reference-count":26,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2004,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To report a case of psoriasiform eruption induced by infliximab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CASE SUMMARY:<\/jats:title>\n                    <jats:p>A 46-year-old woman with enterocutaneous fistula secondary to Crohn's disease developed pruriginous, erythematous, desquamative plaques on her elbows, knees, hands, and buttocks after receiving the second and third doses of intravenous infliximab. Histologic examination showed a lichenoid pattern. No new cutaneous lesions appeared after cessation of infliximab therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION:<\/jats:title>\n                    <jats:p>Several cutaneous reactions secondary to infliximab, a monoclonal antibody against tumor necrosis factor-alfa, have been described. Psoriasiform dermatitis has not been reported as a cutaneous reaction to infliximab, but there have been several previous reports of psoriasiform dermatitis secondary to other drugs. An objective causality assessment revealed that the adverse event was probable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>This is the first report of a clinico-pathologic dissociated pattern of cutaneous reaction showing a histopathologic picture of lichenoid dermatitis resulting from infliximab treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.1c477","type":"journal-article","created":{"date-parts":[[2003,12,5]],"date-time":"2003-12-05T17:18:33Z","timestamp":1070644713000},"page":"54-57","source":"Crossref","is-referenced-by-count":82,"title":["Psoriasiform Eruption Induced by Infliximab"],"prefix":"10.1177","volume":"38","author":[{"given":"Mar\u00eda M","family":"Verea","sequence":"first","affiliation":[{"name":"Mar\u00eda M Verea MD, Clinical Specialist, Department of Dermatology, Hospital Juan Canalejo, La Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Del","family":"Pozo","sequence":"additional","affiliation":[{"name":"Jes\u00fas Del Pozo MD, Clinical Specialist, Department of Dermatology, Hospital Juan Canalejo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Teresa","family":"Yebra-Pimentel","sequence":"additional","affiliation":[{"name":"M Teresa Yebra-Pimentel MD, Clinical Specialist, Department of Pathology, Hospital Juan Canalejo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles","family":"Porta","sequence":"additional","affiliation":[{"name":"Angeles Porta PharmD, Pharmacist, Department of Pharmacy, Hospital Juan Canalejo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Eduardo Fonseca MD, Chief, Department of Dermatology, Hospital Juan Canalejo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2004,1,1]]},"reference":[{"key":"bibr1-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/58.4.307"},{"key":"bibr2-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)00442-0"},{"key":"bibr3-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.4.443"},{"key":"bibr4-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.12.1705"},{"key":"bibr5-aph.1C477","first-page":"250","volume":"23","author":"Hinojosa J.","year":"2000","journal-title":"Gastroenterol Hepatol"},{"key":"bibr6-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70304-1"},{"key":"bibr7-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05246-0"},{"key":"bibr8-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.105948"},{"key":"bibr9-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04954-0"},{"key":"bibr10-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-199905000-00008"},{"key":"bibr11-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70332-X"},{"key":"bibr12-aph.1C477","first-page":"731","volume":"116","author":"Hanauer SB","year":"1999","journal-title":"Gastroenterology"},{"key":"bibr13-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1007\/s003840050182"},{"key":"bibr14-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020888"},{"key":"bibr15-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90632-7"},{"key":"bibr16-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02349.x"},{"key":"bibr17-aph.1C477","first-page":"S401","volume":"42","author":"Kavanaugh A","year":"1999","journal-title":"Arthritis Rheum"},{"key":"bibr18-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441415"},{"key":"bibr19-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.78.915.47"},{"key":"bibr20-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70294-5"},{"key":"bibr21-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.9.1258"},{"key":"bibr22-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1159\/000069965"},{"key":"bibr23-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200305000-00010"},{"key":"bibr24-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.540"},{"key":"bibr25-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103223441207"},{"key":"bibr26-aph.1C477","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1C477","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1345\/aph.1C477","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1C477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:07:36Z","timestamp":1777374456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1C477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.1345\/aph.1C477"],"URL":"https:\/\/doi.org\/10.1345\/aph.1c477","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}